|
|
Dear Readers,
Welcome to the July 2021 edition of the Funding Strategies newsletter! |
Queensland Business Boost Grants Program to open on 30 July 2021 |
The Business Boost grants program provides support to businesses to advance improvements in their efficiency and productivity.
The team at Funding Strategies is standing by to assist you with future planning for your business: - Strategic business planning for innovation or growth;
- Implementing a governance board to guide strategic planning.
Contact us for a quote today via email or phone 07 3160 2840. |
|
Product of the Month
Strategy Sessions Creating a Roadmap with you
A half day strategy session allows us (and you) to put a road map together with our range of tools and options to understand how to move forward, the critical path, how much money the company needs and what steps to take next. |
View our Latest Opportunities |
As always, we invite you to from our website (registration / log-in required, membership is free). |
|
|
|
|
|
|
|
|
|
Introducing Prevatex
Science based probiotics for mothers and infants
|
|
|
|
Prevatex Pty Ltd is a microbiome company founded by a team of experienced biotech executives, scientists and clinicians to develop and bring to market novel probiotic-based biotherapeutics to establish and maintain a traditional, healthy maternal microbiome.
With a strong portfolio of intellectual property, well credentialed management team and blue-chip seed investors, the Prevatex team believes the Company is uniquely positioned to develop and bring to market the next generation of probiotic-based biotherapeutics to establish, restore, and maintain a healthy maternal microbiome.
|
|
|
|
|
|
|
|
TUTIS VReddo Update
TUTIS VReddo signs up QIBA
|
|
|
|
TUTIS VReddo is excited to announce that the Queensland International Business Academy (QIBA) have just signed-up to launch a variety of their courses in Virtual Reality, via TUTIS VReddo’s proprietary VR-enabled immersive learning platform, VReddo LIVE.
QIBA is a leading Australian international RTO who on account of the global pandemic were forced to close all face-to-face classes across all their campus locations. However this has not stifled their desire to inspire their students, it’s just meant they’ve had to innovate.
“We’re excited to provide an innovative way to enhance the student learning experience and believe that VR is the future for providing a more engaging and immersive educational experience for students”, said Mr Helmer Lich, QIBA CEO.
|
|
|
|
|
|
Pharmachal Update
Pharmachal Health Group apply for SSX Listing
|
|
|
|
Pharmachal Health Group are a Melbourne-based pharmaceutical company with a globally-patented, mini-emulsion, drug-in-oil delivery system capable of delivering a wide range of small-molecule APIs (drugs).
Pharmachal's product range includes topical creams and nutritional products, including the breakthrough mini-emulsion lidocaine spray “NOPAYNE”, for which clinical trials were successfully completed under the supervision of world-renowned burns doctor, Professor Fiona Wood AO.
Charles Fridlender, Founder and Executive Director said “The new version of the SSX provides an excellent opportunity for an initial listing before we progress onto a major international exchange.” |
|
|
|
|
|
Bricklet Update
Property investment from only $22,000 |
The Alfred location offers the perfect opportunity for investors to unlock the increased gains from short term leasing. - 1 km from Brisbane CBD
- 3-bedroom I 3-bath I 2 car
- Fully furnished
- Resort style amenities
- Managed by Arise Hotels & Apartments
|
|
|
|
DON’T MISS THIS OPPORTUNITY FOR 8%+ YIELD!
$22,000 per bricklet. Only 60 Bricklets available. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Introducing
Access Investing Limited
"Levelling the Pre-IPO Playing Field for Retail Investors" |
|
|
|
BlueMount Capital client Access Investing is a market offering that provides ordinary (or 'retail') investors with access to private growth & pre-IPO company investments, together with the networks & industry experience of the Access Investing team to source and select prospective investments following a rigorous screening process. |
|
|
|
|
|
Watch the explainer video: Two minutes which explains how Access Investing disrupts the market for private company investing. |
|
|
|
|
|
|
|
Introducing Project Pastio
Project Pastio aims to be the
Leading Plant Protein AgTech company in Australia
|
|
|
|
Project Pastio is an agriculture company focused on unlocking the nutritional potential of forages and grasses in the pastoral value chain. The Company intends to purchase and develop a portfolio of cattle stations and properties to benefit from in-house multi-species high protein/high value forages and grasses, and innovative land management practices.
Project Pastio is looking to establish a fund that proposes to acquire a portfolio of pastoral properties.
|
|
|
|
|
|
|
|
Drillman Update
BlueMount Capital Finalises Complex Deal to assist Drillman’s Acquisition of Global Exploration Company
|
|
|
|
Drilling Equipment Manufacturers Australia Pty Ltd (Drillman), a subsidiary of the M Group of Companies, corporate advisor BlueMount Capital (QLD) Pty Ltd (BlueMount Capital), provided “buy-side” M&A and capital raising support securing capital to complete the Sandvik Exploration acquisition.
The transaction includes the acquisition of exploration rigs; consumables and production stock, customer lists, selected trademarks and patents, and the use of the Sandvik brand name. In 2019, the Sandvik Exploration business had revenues of about SEK 450 million. BlueMount Capital actively identified institutional and industry counterparties including debt and equity providers from Australia and Asia.
BlueMount Capital worked closely with all stakeholders to structure offers, assisted with due diligence and ultimately secured substantial funding from a local credit fund for Australian owned Drillman to complete the acquisition and provide ongoing working capital for the firm. |
|
|
|
|
|
XING Update
Thermo Fisher Scientific Signs Letter of Support for XING
|
|
|
|
BlueMount Capital client XING solves biosecurity testing through rapid immune-protein construct laboratory reagents that aim to improve detection sensitivity and speed to market.
Thermo Fisher Scientific (NYSE: TMO), the world leader in serving science, have signed a letter of support to express their potential interest in XING’s XavTrap® platform, and their desire to collaborate with XING on an initial proof-of-concept study on reagents of interest to Thermo Fisher Scientific.
Thermo Fisher Scientific thinks the XavTrap® platform may have the potential to address key technical and market opportunities not currently served by antibodies and could provide scalable business opportunities across TMO's global research and diagnostic markets. |
|
|
|
|
|
|
|
|
|
|
|
Australia China Business Council Update
We hope you will join us at ACBC's upcoming events!
|
|
|
|
- 28 July: ACBC NSW Health & Ageing: Engagement with China Post-COVID
- 29 July: ACBC NSW Breakfast Roundtable: Building a Chinese Language Website
- 4 August: ACBC NSW Webinar: The Changing Education Landscape in China
- 5 August: Canberra Networking Day 2021 – Online Event
- 11 August: ACBC NSW Webinar: Greater Bay Area Opportunities – Innovation in Financial Services
- 19 August: ACBC QLD – Education Strategies for China 2021 and Beyond
|
|
|
|
|
|
McCormick Harris Update
What’s a harder insurance market got to do with your business?
|
|
|
|
|
|
One of our industry partner, McCormick Insurance, recently wrote an article about the insurance market being a 'hard' or seller's market right now. The article looks at what changes you can expect in a hard market and the effects on the global marketplaces. The article also outlines a few things an individual business in the current hard market. |
|
|
|
|
|
Meet our Team
Flora Mok, Director M&A |
Flora Mok has more than 20 years of professional M&A, tax and accounting experience in Hong Kong, China and Australia. She is a qualified accountant and has proven track record of successfully and efficiently advising on complicated global M&A deals. Flora is a Fellow Member of the Chartered Association of Certified Accountants (UK) and a Member of the Hong Kong Institute of Certified Public Accountants (HK) and CPA Australia.
|
|
|
|
|
|
|
|
|
|
|
|
Funding Strategies Pty Ltd ACN 161 432 123 Authorised Representative for AFSL 230680 Level 5, 15 Astor Terrace, Spring Hill, QLD +61 7 3160 2840 | Funding Strategies website |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
You are receiving this email because you are a valued contact and have provided us with your details in the past. If you ever wish to change your personal details simply update your profile, or to unsubscribe, click the unsubscribe link located at the bottom of any of our emails.
This email is not an offer to invest in securities and is made in accordance with section 708 of the Corporations Act.
If you have received this email in error, please email with the Subject line of "Unsubscribe" or alternatively
click the unsubscribe link located at the bottom of any of our emails. |
|
.jpg "Updates from Funding Strategies")
.jpg "Updates from Funding Strategies")
.jpg "Pharmachal logo"){kind=logo}
.jpg "BlueMount Capital updates")
